Delivery Order SPE2DB22D2006-SPE2DB25FV9WP

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,525.20, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,254.05 firm fixed-price delivery order is for medical supplies, specifically the ZEPBOUND 5 MG/0.5 ML PEN 0.5ML product. The contract has an ultimate completion date of February 4, 2025 and was awarded on February 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,143.87, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,073.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of December 12, 2024. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,537.44, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.S ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,548.23 firm fixed-price delivery order is for 4567486393 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML medical supplies. The contract has a completion date of March 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,431.61, is for the delivery of a specific medical product, the "ZEPBOUND 5 MG/0.5 ML PEN 0.2ML", with a completion date of January 7, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,197.07, is for the delivery of "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" medical supplies. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2025. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,575.48, is a Firm Fixed Price Delivery Order for the supply of "ZEPBOUND 15 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of March 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,850.06, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV9WP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $1,096.55 to provide ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 7/9/25, 9:52 AM